These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Neuroprotective therapy for acute ischaemic stroke: down, but not out. Goldstein LB Lancet; 2004 Feb; 363(9407):414-5. PubMed ID: 14962518 [No Abstract] [Full Text] [Related]
29. Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department. Skobeloff EM; Spivey WH; McNamara RM; Greenspon L JAMA; 1989 Sep; 262(9):1210-3. PubMed ID: 2761061 [TBL] [Abstract][Full Text] [Related]
30. Dose finding study of intravenous magnesium sulphate in transient focal cerebral ischemia in rats. Westermaier T; Zausinger S; Baethmann A; Schmid-Elsaesser R Acta Neurochir (Wien); 2005 May; 147(5):525-32; discussion 532. PubMed ID: 15838594 [TBL] [Abstract][Full Text] [Related]
31. IV magnesium sulfate in the treatment of acute severe asthma: a multicenter randomized controlled trial. Silverman RA; Osborn H; Runge J; Gallagher EJ; Chiang W; Feldman J; Gaeta T; Freeman K; Levin B; Mancherje N; Scharf S; Chest; 2002 Aug; 122(2):489-97. PubMed ID: 12171821 [TBL] [Abstract][Full Text] [Related]
32. Magnesium sulfate therapy in patients with acute neuronal damage: The problem of intravenous administration. Dohi K; Ohtaki H; Shioda S; Aruga T Crit Care Med; 2005 Mar; 33(3):698-9. PubMed ID: 15753782 [No Abstract] [Full Text] [Related]
33. Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache. Corbo J; Esses D; Bijur PE; Iannaccone R; Gallagher EJ Ann Emerg Med; 2001 Dec; 38(6):621-7. PubMed ID: 11719739 [TBL] [Abstract][Full Text] [Related]
34. The use of magnesium sulphate infusions in the management of very severe tetanus. James MF; Manson ED Intensive Care Med; 1985; 11(1):5-12. PubMed ID: 3968303 [TBL] [Abstract][Full Text] [Related]
35. Intravenous magnesium for neuroprotection in acute stroke: clinical hope versus basic neuropharmacology. Gupta VK Stroke; 2004 Dec; 35(12):2758; author reply 2758-9. PubMed ID: 15564568 [No Abstract] [Full Text] [Related]
36. Magnesium for the prevention and treatment of acute mountain sickness. Dumont L; Lysakowski C; Tramèr MR; Junod JD; Mardirosoff C; Tassonyi E; Kayser B Clin Sci (Lond); 2004 Mar; 106(3):269-77. PubMed ID: 14572305 [TBL] [Abstract][Full Text] [Related]
37. [About cavinton therapy of the patients with brain vascular diseases]. Nikitina VV; Pravdina AN; Zapatrina OV Voen Med Zh; 2007 Feb; 328(2):43-5. PubMed ID: 17508611 [No Abstract] [Full Text] [Related]
38. The risks of extending the controversial use of tocolytic magnesium sulfate for the purpose of neuroprotection in preterm labor. Mittendorf R; Roizen NJ; Pryde PG J Perinatol; 2004 Jul; 24(7):465-6. PubMed ID: 15224123 [No Abstract] [Full Text] [Related]
39. Clomethiazole acute stroke study (CLASS): results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients. Wahlgren NG; Ranasinha KW; Rosolacci T; Franke CL; van Erven PM; Ashwood T; Claesson L Stroke; 1999 Jan; 30(1):21-8. PubMed ID: 9880383 [TBL] [Abstract][Full Text] [Related]
40. Randomized controlled trial of oral captopril, of oral isosorbide mononitrate and of intravenous magnesium sulphate started early in acute myocardial infarction: safety and haemodynamic effects. ISIS-4 (Fourth International Study of Infarct Survival) Pilot Study Investigators. Flather M; Pipilis A; Collins R; Budaj A; Hargreaves A; Kolettis T; Jacob A; Millane T; Fitzgerald L; Cedro K Eur Heart J; 1994 May; 15(5):608-19. PubMed ID: 8055999 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]